Although DAM display the decreased gene expression level of Cx3cr1 in mouse models with Aβ plaque deposition [106], CX3CR1 expression progressively increases in the brains of individuals with AD as the disease advances [132]. The gene discussed is CX3CR1; the disease is Alzheimer disease.